HealthKart, a nutrition and wellness platform in Gurugram, had a strong year in India’s direct-to-consumer market. In FY25, their operating income went up to ₹1,313 crore, bringing their total income close to ₹1,400 crore, and their earnings jumped threefold to ₹120 crore.
This big jump in earnings comes after HealthKart got back in the profit zone in FY24. It shows the brand is moving toward steady, profitable growth in India’s quickly growing D2C wellness area.
According to their financial reports, HealthKart’s operating income went up by 29%. This was because of high demand for their nutrition brands like MuscleBlaze, The Protein Zone, TrueBasics, HKVitals, bGreen, Nouriza, and Gritzo. Sales made up 97% of the income, growing to ₹1,277 crore, while services brought in ₹36 crore. Their non-operating income also went up to ₹55 crore in FY25.
The company kept a close watch on costs, which helped profits grow faster than income. Total spending rose 23% to ₹1,273 crore, which is less than the 29% increase in income. The cost of materials, which is the largest expense, rose 26% to ₹623 crore, which is in line with the growth. Advertising costs went up 39% to ₹263 crore, commission costs rose 22% to ₹82 crore, and employee expenses dropped 5% to ₹115 crore. Because of this balance, HealthKart was able to lower its cost per rupee earned to Re 0.97, compared to ₹1.01 in FY24.
These results show that HealthKart is one of the fastest-growing and most profitable D2C brands in India. Their plan, which includes their website, marketplaces, stores, and strong production skills, keeps making their D2C business stronger.
With the support of Peak XV Partners, Temasek, and Sofina, HealthKart has gathered $382 million so far. This makes them one of the top-funded D2C brands, and a key one to watch for future funding or business moves as India’s wellness market grows.
India’s sports nutrition and wellness area has seen a move toward more premium products, and HealthKart is taking advantage of this with strong D2C work, supply chain, and new products. The company also has ₹971 crore in current assets, including ₹73 crore in cash, which makes their financial position even stronger as they grow.
As the D2C market changes in India, HealthKart’s FY25 numbers are a great example of D2C income growth and steady scaling. With earnings up threefold, income close to ₹1,400 crore, and demand for wellness products rising, HealthKart is in a good place to strengthen its hold on India’s premium nutrition market in FY26 and beyond.
